Acuamark DX
  • Technology
    • Publications
    • FAQ
  • Who We Are
    • Leadership
    • Advisors
    • Board of Directors
    • Inclusion and Diversity
    • Code of Conduct
  • News
  • Contact
Acuamark DXAcuamark DX
  • Technology
    • Publications
    • FAQ
  • Who We Are
    • Leadership
    • Advisors
    • Board of Directors
    • Inclusion and Diversity
    • Code of Conduct
  • News
  • Contact

Publications

View the latest publications pertaining to AcuamarkDX.
May 2020

Application of Multiplex Bisulfite PCR–Ligase Detection Reaction–Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer

Read Publication
January 2020

Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection

Read Publication
January 2020

Single‐molecule detection of cancer mutations using a novel PCR‐LDR‐qPCR assay

Read Publication
December 2017

Challenges in Using ctDNA to Achieve Early Detection of Cancer

Read Publication
Acuamark Diagnostics develops technology that allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before cancer becomes untreatable.

Navigation


  • Technology
    • Publications
    • FAQ
  • Who We Are
  • News
  • Contact

Helpful Links


  • Publications
  • Board of Directors
  • FAQ
  • Cookie Policy

Contact Us


101 Avenue Of The Americas
3rd Fl (c/o JLabs)
New York, NY 10013
This email address is being protected from spambots. You need JavaScript enabled to view it.

© 2022 AcuamarkDx | All Rights Reserved | Privacy Policy | Sitemap